Our new analyses reveal that nearly 68% of such tumors express one or more CGB genes at the mRNA level, while our analyses also reveal common CGB expression in tumor types such as thymoma, which has not been previously reported to our knowledge. This evidence concerns the gene CGB3 and neoplasm.